This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Newson, R. Articles by Burney, P. Search for Related Content PubMed PubMed Citation Articles by Newson, R. Articles by Burney, P.

Original Articles

Paracetamol sales and atopic disease in children and adults: an ecological analysis

The authors recently observed that frequent paracetamol use was positively associated with asthma and rhinitis in young adults. Therefore, an ecological analysis was performed to measure international associations between paracetamol sales and atopic disease prevalences in children and adults. Published data from the International Study of Asthma and Allergies in Childhood (ISAAC) on the prevalence of four atopic symptoms in 13-14-yr-olds (112 centres) and 67-yr-olds (66 centres) in 1994/1995, and European Community Respiratory Health Survey (ECRHS) data on the prevalence of asthma symptoms, diagnosed asthma and rhinitis (44 centres), prevalence of atopy, mean bronchial responsiveness and mean total immunoglobulin E levels (34 centres) in young adults in 1991/1992, were used. Their associations with national 1994/1995 per capita paracetamol sales were measured using linear regression. Paracetamol sales were high in English-speaking countries, and were positively associated with asthma symptoms, eczema and allergic rhinoconjunctivitis in 13-14-yr-olds, and with wheeze, diagnosed asthma, rhinitis and bronchial responsiveness in adults. The prevalence of wheeze increased by 0.52% in 13-14-yr-olds and by 0.26% in adults (p<0.0005) for each gram increase in per capita paracetamol sales. These ecological findings require cautious interpretation, but raise the possibility that variation in paracetamol usage may explain some of the variation in atopic disease prevalence between countries.

This article has been cited by other articles:

				T. A. Clayton, D. Baker, J. C. Lindon, J. R. Everett, and J. K. Nicholson From the Cover: Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism PNAS, August 25, 2009; 106(34): 14728 - 14733. [Abstract] [Full Text] [PDF]

				S. Shaheen, J. Potts, L. Gnatiuc, J. Makowska, M. L. Kowalski, G. Joos, T. van Zele, Y. van Durme, I. De Rudder, S. Wohrl, et al. The relation between paracetamol use and asthma: a GA2LEN European case-control study Eur. Respir. J., November 1, 2008; 32(5): 1231 - 1236. [Abstract] [Full Text] [PDF]

				C. Rebordosa, M. Kogevinas, H. T Sorensen, and J. Olsen Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: A birth cohort study Int. J. Epidemiol., June 1, 2008; 37(3): 583 - 590. [Abstract] [Full Text] [PDF]

				T. M. McKeever, S. A. Lewis, H. A. Smit, P. Burney, J. R. Britton, and P. A. Cassano The Association of Acetaminophen, Aspirin, and Ibuprofen with Respiratory Disease and Lung Function Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 966 - 971. [Abstract] [Full Text] [PDF]

				I. Eneli, K. Sadri, C. Camargo Jr, and R. G. Barr Acetaminophen and the Risk of Asthma: The Epidemiologic and Pathophysiologic Evidence Chest, February 1, 2005; 127(2): 604 - 612. [Abstract] [Full Text] [PDF]

				C. Cohet, S. Cheng, C. MacDonald, M. Baker, S. Foliaki, N. Huntington, J. Douwes, and N. Pearce Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood J Epidemiol Community Health, October 1, 2004; 58(10): 852 - 857. [Abstract] [Full Text] [PDF]

				R. G. Barr, C. C. Wentowski, G. C. Curhan, S. C. Somers, M. J. Stampfer, J. Schwartz, F. E. Speizer, and C. A. Camargo Jr. Prospective Study of Acetaminophen Use and Newly Diagnosed Asthma among Women Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 836 - 841. [Abstract] [Full Text] [PDF]

				S O Shaheen, R B Newson, A Sherriff, A J Henderson, J E Heron, P G J Burney, J Golding, and the Alspac Study Team Paracetamol use in pregnancy and wheezing in early childhood Thorax, November 1, 2002; 57(11): 958 - 963. [Abstract] [Full Text] [PDF]

				C.L. SHEEN, J.F. DILLON, D.N. BATEMAN, K.J. SIMPSON, and T.M. MACDONALD Paracetamol toxicity: epidemiology, prevention and costs to the health-care system QJM, September 1, 2002; 95(9): 609 - 619. [Abstract] [Full Text] [PDF]

				M. Calvani Jr, C. Alessandri, and E. Bonci Fever episodes in early life and the development of atopy in children with asthma Eur. Respir. J., August 1, 2002; 20(2): 391 - 396. [Abstract] [Full Text] [PDF]

				A. E. Varner The Increase in Allergic Respiratory Diseases : Survival of the Fittest? Chest, April 1, 2002; 121(4): 1308 - 1316. [Abstract] [Full Text] [PDF]

				C. Janson, J. Anto, P. Burney, S. Chinn, R. de Marco, J. Heinrich, D. Jarvis, N. Kuenzli, B. Leynaert, C. Luczynska, et al. The European Community Respiratory Health Survey: what are the main results so far? Eur. Respir. J., September 1, 2001; 18(3): 598 - 611. [Abstract] [Full Text] [PDF]